A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease

NCT06610526 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

731

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Dapagliflozin

Sponsor

AstraZeneca